Valuation : Almirall, S.A.

Market Cap 2.21B 2.57B 2.08B 1.9B 3.55B 245B 3.58B 24.81B 9.55B 125B 9.64B 9.43B 396B P/E 2026 *
26.2x
P/E 2027 * 18.7x
Enterprise Value 2.12B 2.46B 2B 1.82B 3.4B 235B 3.43B 23.77B 9.15B 119B 9.24B 9.03B 379B EV / Sales 2026 *
1.72x
EV / Sales 2027 * 1.46x
Free-Float
35.93%
Yield 2026 *
2%
Yield 2027 * 2.07%
1 day+0.60%
1 week-2.50%
Current month-1.74%
1 month-5.94%
3 months-8.48%
6 months-15.08%
Current year-21.03%
1 week 10.02
Extreme 10.02
10.5
1 month 10.02
Extreme 10.02
10.7
Current year 10.02
Extreme 10.02
13.98
1 year 10.02
Extreme 10.02
13.98
3 years 7.85
Extreme 7.85
13.98
5 years 7.16
Extreme 7.16
14.58
10 years 7.16
Extreme 7.16
18.5
Manager TitleAgeSince
Chief Executive Officer - 02/11/2022
Director of Finance/CFO 53 31/08/2025
Chief Tech/Sci/R&D Officer - 07/07/2021
Director TitleAgeSince
Director/Board Member - 01/01/2014
Director/Board Member - 01/01/2016
Chairman - 06/05/2022
Date Insider Type Main position Quantity % Market Cap. Importance
6/23/23 A Buy

Executive/Senior Manager

3,000 0.0017%
6/22/23 A Buy 4,340 0.0024%
6/22/23 A Buy

Executive/Senior Manager

5,000 0.0028%
Change 5-day change 1-year change 3-year change Capi.($)
+0.60%-2.50%-8.48%+7.87% 2.55B
-0.11%-3.16%+48.82%+91.49% 1,002B
-0.27%-4.34%+51.52%+65.89% 644B
+1.63%-2.00%+20.49%+71.12% 443B
-0.63%-3.09%+29.84%+34.59% 343B
+0.43%-14.61%+11.32%+27.26% 262B
+0.93%-3.19%-1.31%+8.41% 245B
-2.25%-13.88%+37.33%+47.43% 212B
-0.90%-5.06%-18.47%-57.75% 199B
-0.58%-4.24%+25.65%+90.54% 181B
Average -0.04%-4.91%+19.67%+38.68% 353.22B
Weighted average by Cap. +0.07%-4.38%+31.96%+57.08%

Financials

2026 *2027 *
Net sales 1.23B 1.43B 1.16B 1.06B 1.97B 137B 1.99B 13.8B 5.31B 69.24B 5.36B 5.24B 220B 1.35B 1.57B 1.28B 1.16B 2.17B 150B 2.19B 15.19B 5.85B 76.23B 5.9B 5.77B 242B
Net income 82.4M 95.81M 77.74M 70.82M 132M 9.16B 134M 926M 356M 4.65B 360M 352M 14.76B 115M 134M 109M 99.18M 185M 12.83B 187M 1.3B 499M 6.51B 504M 493M 20.67B
Net Debt -93.03M -108M -87.78M -79.97M -149M -10.34B -151M -1.05B -402M -5.25B -406M -397M -16.66B -228M -265M -215M -196M -366M -25.33B -369M -2.56B -986M -12.85B -995M -973M -40.81B
Logo Almirall, S.A.
Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The Company's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The Company operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.
Employees
2,097
Date Price Change Volume
10/09/26 €10.14 +0.60% 175,590
09/09/26 €10.08 -2.70% 114,215
08/09/26 €10.36 -0.38% 71,822
07/09/26 €10.40 -0.19% 101,827
04/09/26 €10.42 +0.19% 89,852
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
10.14EUR
Average target price
14.30EUR
Spread / Average Target
+41.03%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!